Table 3.
A |
B |
||||||
---|---|---|---|---|---|---|---|
Affymetrix ID | Gene symbol | Gene name | r | p-value | FDR | r |
p-value (unadjusted) |
229222_at | ACSS3 | Acyl-CoA synthetase short-chain family member 3 | −0.37 | p <0.001 | 0.100 | 0.136 | 0.526 |
218665_at | FZD4 | Frizzled homolog 4 (drosophila) | −0.39 | p <0.001 | 0.078 | −0.164 | 0.444 |
209576_at | GNAI1 | Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide 1 | −0.38 | p <0.001 | 0.088 | 0.047 | 0.827 |
209540_at | IGF1 | Insulin-like growth factor 1 (somatomedin C) | −0.41 | p <0.001 | 0.064 | 0.531 | 0.007 |
201505_at | LAMB1 | Laminin, beta 1 | −0.40 | p <0.001 | 0.064 | −0.061 | 0.777 |
212274_at | LPIN1 | Lipin 1 | −0.37 | p <0.001 | 0.092 | −0.327 | 0.119 |
212636_at | QKI | Quaking homolog, KH domain RNA binding (mouse) | −0.41 | p <0.001 | 0.064 | NA | |
227543_at | RNASEH2C | Ribonuclease H2, subunit C | 0.37 | p <0.001 | 0.096 | −0.010 | 0.963 |
222669_s_at | SBDS | Shwachman-Bodian-Diamond syndrome/Shwachman-Bodian-Diamond syndrome pseudogene | −0.38 | p <0.001 | 0.088 | −0.407 | 0.048 |
201811_x_at | SH3BP5 | SH3-domain binding protein 5 (BTK associated) | −0.44 | p < 0.001 | 0.051 | −0.183 | 0.392 |
218077_s_at | ZDHHC3 | Zinc finger, DHHC-type containing 3 | 0.37 | p < 0.001 | 0.097 | −0.052 | 0.809 |
210275_s_at | ZFAND5 | Zinc finger, AN1-type domain 5 | −0.38 | p < 0.001 | 0.088 | 0.284 | 0.179 |
Part A is extracted from Supplemental Table S5 in Reppe et al.9 and includes the bone BMD correlated transcripts [with r, p and false discovery rate (FDR)] having corresponding thigh muscle transcripts that changed upon training (pooled healthy and OP). Part B is based on a subset of healthy (n = 12) or OP (n = 12) iliac bone and pelvic muscle donors presented in Table S1, group C and D, and Supplemental Table S4.
BMD, bone mineral density; FDR, false discovery rate; OP, osteoporosis; RNA, ribonucleic acid; mRNA, messenger RNA.